The Valley Desk

ArticleBloodPublished

Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Blood
Published
Subject terms
Humans; Lymphoma, Mantle-Cell; Piperidines; Pyrazoles; Pyrimidines; Adenine; Antineoplastic Combined Chemotherapy Protocols; Prognosis; Mutation; Aged; Aged, 80 and over; Female
PubMed ID
40101138
Added to directory
Source checked

Report a correction or request removal